Effects of Serum from a Fibrodysplasia Ossificans Progressiva Patient on Osteoblastic Cells - Open Journal of Endocrine and Metabolic Diseases

OJEMD > Vol.2 No.1, February 2012

Open Journal of Endocrine and Metabolic Diseases

Volume 2, Issue 1 (February 2012)

ISSN Print: 2165-7424 ISSN Online: 2165-7432

Google-based Impact Factor: 0.39 Citations

Effects of Serum from a Fibrodysplasia Ossificans Progressiva Patient on Osteoblastic Cells ()

HTML XML

Download as PDF (Size: 251KB) PP. 1-6

DOI: 10.4236/ojemd.2012.21001 3,953 Downloads 9,220 Views Citations

Author(s)

Itoko Hisa, Akira Kawara, Takenobu Katagiri, Toshitsugu Sugimoto, Hiroshi Kaji

Affiliation(s)

Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Division of Pathophysiology, Research Center for Genomic Medicine, Saitama Medical University, Japan.
Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.
Kawara Clinic, Kobe, Japan.

ABSTRACT

Introduction: Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of skeletal malformations and progressive extraskeletal ossification. Patients and Methods: In the present study, we present a case of FOP with marked progressive ossification of extraskeletal tissues. We investigated whether soluble factors in serum would affect the osteoblast phenotype by examining the effects of serum from this patient and control subjects on mouse osteoblastic MC3T3-E1 cells. Results: The clinical findings of this patient were compatible with FOP, and direct sequence analysis of genomic DNA demonstrated the presence of a heterozygous 617G> A (R206H) mutation of activin type 1 receptor (ACVR1). Serum from the FOP patient enhanced the level of alkaline phosphatase (ALP) in Western blotting, compared with serum from the control, in MC3T3-E1 cells. Moreover, serum from the FOP patient enhanced the levels of ALP, osteocalcin and bone morphogenetic protein-2 mRNA in these cells. Conclusion: We presented a case of FOP with progressive ossification in extra-skeletal tissues with ACVR1 mutation. The present data suggest that the serum from this patient includes some soluble factors, which might enhance the osteoblast differentiation and BMP-2 expression in mouse osteoblastic cells.

KEYWORDS

Fibrodysplasia Ossificans Progressiva; Osteoblast; Bone Morphogenetic Protein

Share and Cite:

Hisa, I. , Kawara, A. , Katagiri, T. , Sugimoto, T. and Kaji, H. (2012) Effects of Serum from a Fibrodysplasia Ossificans Progressiva Patient on Osteoblastic Cells. Open Journal of Endocrine and Metabolic Diseases, 2, 1-6. doi: 10.4236/ojemd.2012.21001.

Cited by

[1]	Muscle Health
	New Horizons in Osteoporosis Management, 2022

[2]	NF-κB/MAPK activation underlies ACVR1-mediated inflammation in human heterotopic ossification
	2018

[3]	Role of osteoclasts in heterotopic ossification enhanced by fibrodysplasia ossificans progressiva-related activin-like kinase 2 mutation in mice
	Journal of bone and mineral metabolism, 2015

[4]	фибродисплазия у детей (обзор литературы и анализ пяти клинических случаев)
	2015

[5]	Прогрессирующая оссифицирующая фибродисплазия у детей (обзор литературы и анализ 5 клинических случаев)
	2014

[6]	Fibrodysplasia ossificans progressiva-related activated activin-like kinase signaling enhances osteoclast formation during heterotopic ossification in muscle tissues
	2014

[7]	Interaction between Muscle and Bone
	Journal of bone metabolism, 2014

[8]	Alternative formats
	H Kaji - synapse.koreamed.org, 2014

[9]	Fibrodysplasia ossificans progressiva-related activated activin-like kinase signaling enhances osteoclast formation during heterotopic ossification in muscle tissues.
	Journal of Biological Chemistry, 2014

[10]	Fibrodysplasia ossificans progressiva in children (review and clinical analysis of 5 case reports)
	2014

[11]	Fibrodysplasia ossificans progressiva-related activated activin-like kinase signaling enhances osteoclast formation during heterotopic ossification in muscle …
	Journal of Biological …, 2014

[12]	Sarcopenia: definition, epidemiology, and pathophysiology
	Journal of bone metabolism, 2013

[13]	Linkage between muscle and bone: common catabolic signals resulting in osteoporosis and sarcopenia
	Current Opinion in Clinical Nutrition & Metabolic Care, 2013

[14]	Serum bisphenol A concentration in postmenopausal women with osteoporosis
	Journal of bone metabolism, 2012

Journals Menu

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies